World Wires · story 8217 · unverified · 1 source(s)

Zealand Pharma to Present Phase 2 ZUPREME-1 Trial Data at EASD 2026

Zealand Pharma announced upcoming presentations of petrelintide trial data at the EASD 2026 conference and publication in The Lancet.

Open in the desk

Coverage

• Zealand Pharma to Present Phase 2 ZUPREME-1 Trial Data at EASD 2026 GlobeNewswire: public companies · tier D · clear net · 2026-09-29 22:03 UTC

What this site indexes